Compagnie Lombard Odier SCmA’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-169,191
Closed -$30M 573
2020
Q1
$30M Buy
169,191
+19,683
+13% +$3.71M 1.26% 22
2019
Q4
$28.6M Sell
149,508
-112,313
-43% -$20.3M 1.09% 24
2019
Q3
$44.1M Sell
261,821
-35,012
-12% -$5.7M 1.84% 17
2019
Q2
$49.7M Sell
296,833
-20,306
-6% -$2.81M 2.02% 15
2019
Q1
$46.4M Sell
317,139
-62,339
-16% -$9.04M 1.92% 15
2018
Q4
$50.7M Sell
379,478
-44,953
-11% -$7.37M 2.08% 12
2018
Q3
$80.8M Buy
424,431
+69,587
+20% +$12.8M 2.83% 7
2018
Q2
$59.2M Buy
354,844
+17,065
+5% +$2.74M 2.17% 11
2018
Q1
$56.8M Sell
337,779
-305,613
-48% -$51.3M 2.07% 13
2017
Q4
$105M Buy
643,392
+338,723
+111% +$60.8M 1.89% 12
2017
Q3
$62.4M Buy
304,669
+18,868
+7% +$4.39M 2.21% 9
2017
Q2
$69.5M Buy
285,801
+5,869
+2% +$1.38M 2.41% 9
2017
Q1
$66.9M Sell
279,932
-114,819
-29% -$26.7M 2.26% 10
2016
Q4
$82.9M Buy
394,751
+95,722
+32% +$19.8M 2.43% 9
2016
Q3
$68.9M Buy
299,029
+89,307
+43% +$21.8M 2.01% 9
2016
Q2
$48.5M Buy
209,722
+205,251
+4,591% +$47.3M 1.41% 16
2016
Q1
$1.2M Buy
+4,471
New +$1.28M 0.04% 229

Other funds holding AGN

Compagnie Lombard Odier SCmA's AGN Position: Q2 2020 in Review

Compagnie Lombard Odier SCmA sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 169,191 shares — an estimated $30M sold.

Compagnie Lombard Odier SCmA first reported a position in AGN in Q1 2016 and held it in 17 quarters. The position peaked at $105M in Q4 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Compagnie Lombard Odier SCmA reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 169,191 Allergan plc shares in Q2 2020, an estimated $30M.
  • Compagnie Lombard Odier SCmA first reported a position in Allergan plc in Q1 2016 and held it in 17 quarters.
  • Compagnie Lombard Odier SCmA's Allergan plc position peaked at $105M in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2020, filed 14 Aug 2020.